Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections
- 29 February 2008
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 60 (2), 163-167
- https://doi.org/10.1016/j.diagmicrobio.2007.08.008
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005
- Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin BJournal of Antimicrobial Chemotherapy, 2005
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 2003
- Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 2003
- Stability of Colistin and Colistin Methanesulfonate in Aqueous Media and Plasma as Determined by High-Performance Liquid ChromatographyAntimicrobial Agents and Chemotherapy, 2003
- Simple Method for Assaying Colistin Methanesulfonate in Plasma and Urine Using High-Performance Liquid ChromatographyAntimicrobial Agents and Chemotherapy, 2002
- Liquid chromatography of polymyxin B sulphateJournal of Chromatography A, 2000
- Polymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative BacteriaAnnals of Pharmacotherapy, 1999
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999